What to know about the recall of atorvastatin pills for lowering cholesterol
Summary
In October 2025, a large recall began for atorvastatin, a drug used to lower cholesterol, due to manufacturing problems affecting how the pills dissolve. The recall, issued by Ascend Laboratories, involves 142,000 bottles of the drug, impacting many patients. The FDA has labeled this recall as Class II, meaning the drug could have temporary side effects but is still better taken than not.Key Facts
- Atorvastatin is used to lower cholesterol and is the generic version of the drug Lipitor.
- Over 115 million atorvastatin prescriptions are filled yearly in the U.S.
- Ascend Laboratories recalled approximately 142,000 bottles of atorvastatin on September 19, 2025.
- The FDA classified the recall as Class II, indicating potential temporary or reversible health issues.
- The problem with the pills is that they did not dissolve properly, affecting their effectiveness.
- The defective pills were made from November 2024 to September 2025.
- Patients are advised not to stop taking atorvastatin without consulting their healthcare provider.
- Bottles from Ascend Laboratories can be identified by checking the prescription label for certain codes.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.